Current reimbursement models in Wisconsin compensate pharmacies for the cost of the medication and the dispensing fees associated with providing a naltrexone injection. However, these models currently do not cover the time (in minutes) associated with the cost to administer a naltrexone injection in the pharmacy, which can be a significant expense to individual pharmacies and a barrier to service provision in their community.
To help pharmacies better understand their total costs and time associated with providing injectable naltrexone, we developed this Injectable Naltrexone Administrative Cost Estimator Tool. The purpose of this tool is to gather information associated with the provision of a naltrexone injection for both a New Patient and a Returning Patient in your pharmacy. The Injectable Naltrexone Administrative Cost Estimator Tool should only be completed by pharmacies currently offering an injectable naltrexone service.
Upon completion of the Injectable Naltrexone Administrative Cost Estimator Tool, you will be provided with an Injectable Naltrexone Administrative Costs and Time Report. The report represents the costs and time in your pharmacy to provide a naltrexone injection to new and returning patients. The report also provides a comparison using summary/aggregate data provided by all pharmacies that have completed this cost estimator.
Completion of this Injectable Naltrexone Administrative Cost Estimator Tool is entirely voluntary.
Let's Get Started!
Please carefully review each question. You will first answer a few General Information questions about your pharmacy so that we can personalize the report. You should then open the sections associated with providing a naltrexone injection to a New Patient and a Returning Patient and follow the instructions for answering the questions in each section.
Please answer all questions so that we can provide you with the most accurate report. When all questions have been answered click SUBMIT to generate your Injectable Naltrexone Administrative Costs and Time Report.